跳至主要内容
临床试验/CTRI/2024/05/067283
CTRI/2024/05/067283尚未招募4 期

A Randomized Trial Comparing Albumin-Bound Paclitaxel-Carboplatin to Solvent-Based Paclitaxel-Carboplatin for First-Line Chemotherapy in Stage Ic-IV Ovarian Carcinoma: A Study at a Tertiary Healthcare Institute in the Sub-Himalayan Region - NI

Pharmacology Department Paraclinical Block Dr RPGMC Kangra at Tanda HP India0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Willing adult patient giving written informed consent. Karnofsky Performance Scale (KPS) =70
  • No medical co-morbidities like DM, HTN Normal routine blood investigations.
  • The study will include all the newly diagnosed consenting patient of stage Ic- IV ovarian cancer patient.

排除标准

  • Known case of DM or HTN or any neuropathic disorder. Patient not willing to give written informed consent.
  • Pregnant and Lactating females.
  • Patient already on treatment with study drug.
  • Patients with known contraindication or refractoriness to study drugs.

研究者

发起方
Pharmacology Department Paraclinical Block Dr RPGMC Kangra at Tanda HP India

相似试验